Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
about
Adult outcomes of childhood-onset rheumatic diseasesEffectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart AssociationThe Association Between Sjögren Syndrome and Adverse Postoperative Outcomes: A Historical Cohort Study Using Administrative Health DataMyocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis.Impaired flow-mediated vasodilatation is associated with increased left ventricular mass in a multiethnic population. The Northern Manhattan Study.Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus.Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment.The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in WomenEffects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulationValidated methods for assessment of subclinical atherosclerosis in rheumatology.A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus.TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations.Pulse Wave Velocity, Intima Media Thickness, and Flow-mediated Dilatation in Patients with Normotensive Normoglycemic Inflammatory Bowel Disease.Blood pressure and vascular dysfunction underlie elevated cerebral blood flow in systemic lupus erythematosus.Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample surveyCardiovascular and disease-related predictors of depression in systemic lupus erythematosus.Cardiovascular disease prevention in women: are we up to date?The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis.Rheumatoid arthritis vs osteoarthritis in patients receiving total knee arthroplasty: perioperative outcomes.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Lack of antilipoprotein lipase antibodies in Takayasu's arteritis.Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune DiseasesRelationship between asymmetric dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis.Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease.High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.What do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women?Gender disparity in cardiovascular disease: bias or biology?CD154: the atherosclerotic risk factor in rheumatoid arthritis?Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery.Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: a systematic review and meta-analysis of literature studies.
P2860
Q27690838-F9695178-6471-4BCC-AB30-DAC616974502Q30501645-D5119AA8-4C62-4ACC-ADFB-2C8D3CE50D65Q30989911-99465333-ECF5-49E4-8A1A-CAB865083A04Q33760303-6A88B77E-B347-47EA-AC7C-C462C520D4D2Q33762816-29B7B562-11F3-46BB-A022-AD1D3BB86E05Q33784693-730221A5-E772-4FDD-92FD-E86527981B31Q33792554-FD152E07-09E3-4679-9221-75AA74A54A1FQ33917513-B30851BC-2C17-4835-ACB7-73C6A293DE15Q33937394-36E570AD-19FA-4F1E-AECD-EF124B78105AQ34164481-A39B60E9-7165-42F2-ABED-5C5B4141E0B6Q34322432-12B2EB55-7992-44C1-9256-B9B455E4D8FBQ34571799-585E374A-CB15-4B49-9094-06550FC3F2F8Q34795273-24DC70D5-3303-44C0-8214-F61E3F907547Q35071632-6932FF82-27E4-4B95-93B0-234E9BB6607BQ35121150-5B37FAAC-B797-4DA1-B38B-6DEF54B5E561Q35559422-E8D38DCB-810E-4447-91DD-B37382E112D4Q35670684-3B8E38A3-BC74-47D2-A5D0-2162B9CF4F77Q36699106-B620CFFA-CB27-4191-8B45-897238A4C1A7Q36901827-14836886-FFCB-4FE7-B05D-084169615837Q36903269-5621940B-D163-4F3E-A435-151D2A92ED86Q37019825-3AA9AE1D-EE8D-4CB2-9769-AA96D9E47341Q37040785-3B0A72F5-6755-4EA6-B51F-1E5183CE5134Q37144730-1B4EA0F5-7D87-4DAD-A2DE-879874AA6161Q37201007-10408972-E75F-4666-9B15-D054AE68A479Q37251490-A9D88B52-B39B-4DE4-940D-587EC12BB5D9Q37259402-64D12EAE-FFB8-4BDC-A4E2-ACE4504ECCB0Q37294162-4A1E7CDE-40A6-4671-AE1F-4C9FA2ABB43DQ37327034-0732814E-3CBA-492F-B31F-8B2A8420679FQ37385275-2044584D-0D35-4A89-878A-AEC98020202BQ37436638-36D6483F-0BCC-4755-9BE0-2F24E2B8B14CQ37499363-E3119F4B-FC2A-45F6-B992-710EDBB4F04BQ37635186-B61C24A9-98B8-4ECC-BD9F-266B69826842Q37670939-75D1FABA-59C6-4362-A02D-52BCA38C33E0Q37824302-FF7CD52F-1334-4947-AAB5-543D5D6988E0Q37929661-89C98B68-1F8A-484D-8CE2-4031FD780FC8Q38067775-D99F2A33-6200-40A3-897A-970E9E127B3DQ38083874-0D96FEB6-8011-4242-8F2F-BBD4FF45011AQ38124279-5B89B1A8-D76E-428A-A2F7-1FB2F8F90E6FQ38241501-66CFB785-7F7D-4190-A47A-0575254F0FF1Q38580767-CA7B75E8-53D7-46B0-AA88-6C963BABFC2F
P2860
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
@en
type
label
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
@en
prefLabel
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
@en
P2860
P1476
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
@en
P2093
Jane E Salmon
Mary J Roman
P2860
P356
10.1016/J.AMJMED.2008.06.010
P407
P433
10 Suppl 1
P577
2008-10-01T00:00:00Z